Waist circumference, body mass index and waist to hip ratio for prediction of the metabolic syndrome in Chinese

2009 ◽  
Vol 19 (8) ◽  
pp. 542-547 ◽  
Author(s):  
F. Wang ◽  
S. Wu ◽  
Y. Song ◽  
X. Tang ◽  
R. Marshall ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Body Mass Index ◽  
Waist Circumference ◽  
Body Mass ◽  
Waist To Hip Ratio ◽  
The Metabolic Syndrome

scholarly journals The Metabolic Syndrome among Postmenopausal Women in Gorgan

2012 ◽  
Vol 2012 ◽  
pp. 1-6 ◽  
Author(s):  
Abdoljalal Marjani ◽  
Sedigheh Moghasemi
Keyword(s):  
Metabolic Syndrome ◽  
Body Mass Index ◽  
Waist Circumference ◽  
Postmenopausal Women ◽  
Body Mass ◽  
Hdl Cholesterol ◽  
Waist To Hip Ratio ◽  
Positive Correlation ◽  
The Metabolic Syndrome ◽  
The Mean

Introduction. The present study aimed to assess the metabolic syndrome among postmenopausal women in Gorgan, Iran.Materials and Methods. The study was conducted on hundred postmenopausal women who were referred to the health centers in Gorgan. Metabolic syndrome was diagnosed using Adult Treatment Panel III (ATP III) guidelines.Results. The mean body mass index, waist circumference, hip, circumference waist-to-hip ratio, diastolic blood pressure, and triglyceride and fasting blood glucose levels were significantly high among postmenopausal women with metabolic syndrome, but the mean HDL-cholesterol was significantly low (P<0.05). Overall prevalence of metabolic syndrome was 31%. Body mass index and waist circumference had a positive correlation with a number of metabolic syndrome factors (P<0.001). Body mass index, waist circumference, and waist-to-hip ratio had a positive correlation with each other (P<0.001). BMI had relatively high correlation with WC (P<0.001).Conclusions. Our results show that postmenopausal status might be a predictor of metabolic syndrome. Low HDL-cholesterol level and high abdominal obesity are the most frequent characteristics in comparison to other metabolic components. Our study also showed some related factors of metabolic syndrome among postmenopausal women. These factors may increase cardiovascular risk among postmenopausal women with metabolic syndrome.

Age, obesity and inflammation at baseline predict the effects of testosterone administration on the metabolic syndrome

2011 ◽  
Vol 6 (1) ◽  
Author(s):  
Farid Saad ◽  
Ahmad Haider ◽  
Erik J. Giltay ◽  
Louis J.G. Gooren
Keyword(s):  
Metabolic Syndrome ◽  
Body Mass Index ◽  
Waist Circumference ◽  
Body Mass ◽  
Ldl Cholesterol ◽  
Density Lipoprotein ◽  
Serum Testosterone ◽  
Waist Size ◽  
The Metabolic Syndrome ◽  
Testosterone Administration

AbstractTestosterone administration to hypogonadal men improves the metabolic syndrome. This study analyzed whether age, serum testosterone, body mass index/waist circumference, increment in testosterone values and C-reactive protein (CRP) predicted the outcome of testosterone administration.A total of 110 mainly elderly men, aged between 18 and 83 years (mean±SD=59.6±8.0) with baseline serum testosterone of 5.8–12.1 nmol/L (mean±SD=9.3±1.7) (n>14.0 nmol/L), received parenteral testosterone undecanoate whereupon serum testosterone normalized between 3 and 24 months.(i) The lower the baseline testosterone, the stronger the decreases in waist size and triglycerides. (ii) The greater the increment in serum testosterone, the stronger the decreases in low-density lipoprotein (LDL) cholesterol, triglycerides and glucose. (iii) Older age was associated with stronger beneficial effects on waist size, glucose and all lipids, but a small negative effect on high-density lipoprotein cholesterol. (iv) Obese men and men with the largest waist circumference showed the strongest declines over 2 years in weight, waist circumference and body mass index (BMI), and also in total cholesterol, triglycerides and glucose. Baseline BMI predicted a stronger decline in LDL cholesterol, but a smaller decline in CRP levels. (v) Higher baseline CRP predicted larger declines in levels of triglycerides, glucose and CRP. (vi) In the multivariate model, age, BMI and CRP were independent predictors of the strongest benefit of testosterone treatment on the metabolic syndrome.Older men, particularly when obese with chronic low-grade inflammation benefited most of normalizing their testosterone levels, preferably if they reached mid-normal reference values.

Abstract P250: How to Successfully Manage Adolescents’ Metabolic Syndrome. Keep it Simple!

Circulation ◽  
2013 ◽  
Vol 127 (suppl_12) ◽  
Author(s):  
Julie St-Pierre ◽  
Charles B Thibault ◽  
Johanne Harvey ◽  
Helene Fortin ◽  
JoAnnie Lapointe ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Body Mass Index ◽  
Waist Circumference ◽  
Motivational Interviewing ◽  
Body Mass ◽  
Weight Reduction ◽  
Lifestyle Changes ◽  
The Metabolic Syndrome ◽  
Family Approach

Background: The metabolic syndrome prevalence in adolescents is still rising (with up to 8% in some populations); this increase is mainly attributable to the obesity epidemic. Consequently, the long-term cardiovascular risk of these adolescents is very high. Unfortunately, despite this elevated risk, motivation and adherence to weight reduction programs still remain very low. Hypothesis: To verify if the combination of motivational interviewing, nutritional and physical education, and a close follow-up in a multidisciplinary, family-based weight-reduction pediatric clinic is effective to initiate and sustain beneficial lifestyle changes at 6 months. Subjects and Method: Fifty (50) families with adolescents (10-17 years old) characterized by obesity and metabolic syndrome were recruited with their families. The cardiometabolic risk profile (including body mass index, waist circumference, blood pressure, glucose, insulin, lipids and apolipoprotein B levels) of every subject was evaluated and explained to the adolescent and his/her parents. With motivational interviewing techniques and educative approaches, adolescents were brought to set up, at the first visit, a one month, one health challenge change. In subsequent visits, anthropometric measurements were recorded and, based on their first month’s success, new healthy challenges were proposed by the adolescent. Results: Adolescents participating in this program were initially highly motivated to initiate a one month healthy challenge with an average score of 7/10. Eighty percent of them chose to stop drinking juice or soda beverages as their first challenge. At one month, over 80% of them observe a weight reduction or no weight gain. At this point, the adolescents’ perception of success is the main source of motivation to introduce new health challenges in their life. At 3 and 6 months, healthy habits are still present in over 70% of them. Interestingly, these changes are accompanied by modifications in anthropometric covariables. At 6 months, we observe a significant reduction of body mass index (p=0.027) and waist circumference (p=0.047) in addition to a trend towards a reduction of mean weight (p=0.054). Conclusion: With counselling based on education, motivational techniques and a family approach, a high proportion of adolescents have initiated and maintained healthy changes. At 6 months, waist circumference reduction was the strongest change. This combined familial approach appears promising to reduce metabolic syndrome prevalence in adolescents. The prospective data collection is still ongoing, with the first adolescents recruited now reaching the one-year follow-up.

scholarly journals Predictors of Metabolic Syndrome in the Iranian Population: Waist Circumference, Body Mass Index, or Waist to Hip Ratio?

Cholesterol ◽  
2013 ◽  
Vol 2013 ◽  
pp. 1-6 ◽  
Author(s):  
Mojgan Gharipour ◽  
Nizal Sarrafzadegan ◽  
Masoumeh Sadeghi ◽  
Elham Andalib ◽  
Mohammad Talaie ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Body Mass Index ◽  
Waist Circumference ◽  
Body Mass ◽  
Iranian Population ◽  
Lower Sensitivity ◽  
Roc Curve Analysis ◽  
Anthropometric Parameters ◽  
Cut Points ◽  
Waist To Hip Ratio

This study aimed to investigate whether body mass index (BMI), waist circumference (WC), or waist to hip ratio (WHR) could be a better predictor of metabolic syndrome and, if so, what would be the cutoff points for these surrogates to appropriately differentiate metabolic syndrome in different age and sex subgroups. Methods. The present cross-sectional study was conducted on a sample of Isfahan Cohort Study (ICS). In total, 468 individuals (194 with and 274 subjects without metabolic syndrome) according to the National Cholesterol Education Program’s Adult Treatment Panel III (ATP-III) criteria were selected. Anthropometric indices were measured and plotted using receiver-operating characteristic (ROC) curves. Results. According to ROC curve analysis, WC and WHR parameters were better indicators of metabolic syndrome compared to BMI in women, whereas in men WHR had a lower discriminating value compared to the other two parameters. Among these three anthropometric parameters, BMI had a lower sensitivity and WC and WHR both had a higher sensitivity for predicting metabolic syndrome in women compared with in men. The cut points for WC were nearly equal in men and women, 90.3 versus 90.0, respectively. Women had higher cut points for BMI (28.5 kg/m2) compared to men (26.0 kg/m2). Our results showed the highest sensitivity and specificity for WC cut points specially in women. To predict metabolic syndrome, we looked into optimal age-specific cut points for BMI, WC, and WHR. The results indicated that WC had the highest discriminating value compared to other indicators in the different age subgroups. The optimal cut points for all three parameters gradually increased with age. Conclusion. Our results demonstrated that regardless of gender and age variables, WC could be a preferred parameter for predicting metabolic syndrome compared to BMI and WHR in Iranian population.

scholarly journals Monitoring of the Metabolic Syndrome in Psychiatric Inpatients

2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
J. Cordes ◽  
G. Regenbrecht ◽  
M.W. Agelink ◽  
J. Zielasek ◽  
K.G. Kahl
Keyword(s):  
Metabolic Syndrome ◽  
Body Mass Index ◽  
Waist Circumference ◽  
Body Mass ◽  
Visceral Fat ◽  
Inpatient Treatment ◽  
Fasting Glucose ◽  
The Body ◽  
The Metabolic Syndrome ◽  
Increased Risk

In this naturalistic observational study carried out in an inpatient treatment setting we as yet surveyed the parameters of the metabolic syndrome. A weekly monitoring procedure was implemented. The analysis included data of 350 patients over a time of 12 weeks. The last observation carried forward method was applied. Additionally we are evaluating the informative value of visceral body fat percentage as measured by a body composition analyzer. The patients showed a weight increase over the first 12 weeks (mean increase: 0.87 kg, p < .001) as well as an increase of the body mass index (mean increase: 0.45 kg/m2, p < .001). Accordingly, waist circumference (mean increase: 1.06 cm, p = .007) and visceral fat index (mean increase: 0.19, p = .007) increased. No worsening of fasting glucose and blood lipid concentrations was detected. Spearmens coefficient indicated correlations between visceral fat index and body mass index (ρ = .77; p < .001), waist circumference (ρ = .70; p < .001), and triglyceride concentrations (ρ = .39; p < .001). Correlations between visceral fat index and fasting glucose (ρ = .18; p = .019), and visceral fat index and total cholesterol (ρ = .16; p = .049) were weak but also significant. In contrast, the HDL cholesterol showed a negative relation with ρ < -.39 at each point in time (p < .001).We conclude that psychiatric patients are at increased risk for the development of metabolic alterations during inpatient treatment. The possible underlying mechanisms of this interaction are discussed.

scholarly journals The Influence of Anthropometric Indices and Intermediary Determinants of Hypertension in Bangladesh

2021 ◽  
Vol 18 (11) ◽  
pp. 5646
Author(s):  
Sally Sonia Simmons ◽  
John Elvis Hagan ◽  
Thomas Schack
Keyword(s):  
Public Health ◽  
Body Mass Index ◽  
Waist Circumference ◽  
Body Mass ◽  
Odds Ratio ◽  
Height Ratio ◽  
Anthropometric Parameters ◽  
Anthropometric Indices ◽  
Waist To Hip Ratio ◽  
Waist To Height Ratio

Hypertension is a major public health burden in Bangladesh. However, studies considering the underlying multifaceted risk factors of this health condition are sparse. The present study concurrently examines anthropometric parameters and intermediary factors influencing hypertension risk in Bangladesh. Using the 2018 World Health Organisation (WHO) STEPwise approach to non-communicable disease risk factor surveillance (STEPS) study conducted in Bangladesh and involving 8019 nationally representative adult respondents, bivariate and multivariate logistic regression analyses were performed to determine the association between anthropometrics, other intermediary factors and hypertension. The regression results were presented using the odds ratio (OR) and adjusted odds ratio (AOR) at 95% confidence intervals (CIs). The risk of hypertension was higher among females and males who were 40 years and older. However, among females, those who were age 60 years and older were more than twice and thrice more likely to be hypertensive compared to those in the younger age groups (18–39, 40–59). Females who were obese (body mass index [BMI], waist to hip ratio [WHR], waist to height ratio [WHtR]) or had high waist circumference [WC] were twice as likely to be hypertensive. Males and females who were physically active, consuming more fruits and vegetables daily and educated had lower odds of developing hypertension. Key findings suggest that the association between anthropometric indices (body mass index [BMI], waist to hip ratio [WHR], waist to height ratio [WHtR]), waist circumference [WC]), other intermediary determinants (e.g., education, physical activity) and hypertension exist across gender and with increasing age among adults in Bangladesh. Developing appropriate public health interventions (e.g., regular assessment of anthropometric parameters) for early identification of the risk and pattern of hypertension through appropriate screening and diagnosis is required to meet the specific health needs of the adult Bangladesh population.

scholarly journals The effects of metformin plus sulfonylurea therapy on clinical features of the metabolic syndrome

2010 ◽  
Vol 63 (9-10) ◽  
pp. 611-615 ◽  
Author(s):  
Branka Koprivica ◽  
Teodora Beljic-Zivkovic ◽  
Tatjana Ille
Keyword(s):  
Insulin Resistance ◽  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Metabolic Syndrome ◽  
Body Mass Index ◽  
Waist Circumference ◽  
Glycemic Control ◽  
Body Mass ◽  
Combined Therapy

Introduction. Insulin resistance is a well-known leading factor in the development of metabolic syndrome. The aim of this study was to evaluate metabolic effects of metformin added to sulfonylurea in unsuccessfully treated type 2 diabetic patients with metabolic syndrome. Material and methods. A group of thirty subjects, with type 2 diabetes, secondary sulfonylurea failure and metabolic syndrome were administered the combined therapy of sulfonylurea plus metformin for six months. Metformin 2000 mg/d was added to previously used sulfonylurea agent in maximum daily dose. Antihypertensive and hypolipemic therapy was not changed. The following parameters were assessed at the beginning and after six months of therapy: glycemic control, body mass index, waist circumference, blood pressure, triglycerides, total cholesterol and its fractions, homeostatic models for evaluation of insulin resistance and secretion (HOMA R, HOMA B) and C- peptide. Results. Glycemic control was significantly improved after six months of the combined therapy: (fasting 7.89 vs. 10.61 mmol/l. p<0.01; postprandial 11.12 vs. 12.61 mmol/l. p<0.01, p<0.01; glycosylated hemoglobin 6.81 vs. 8.83%. p<0.01). the body mass index and waist circumference were significantly lower (26.7 vs. 27.8 kg/m2, p<0.01 and 99.7 vs. 101.4 cm for men, p<0.01; 87.2 vs. 88.5 for women, p<0.01). Fasting plasma triglycerides decreased from 3.37 to 2.45 mmol/l (p<0.001) and HOMA R from 7.04 to 5.23 (p<0.001). No treatment effects were observed on blood pressure, cholesterol, and residual insulin secretion. Conclusion. Administration of metformin in type 2 diabetes with metabolic syndrome decreased cardiovascular risk factors by reducing glycemia, triglycerides, BMI, central obesity and insulin resistance.

Sign in / Sign up

Export Citation Format

Share Document